Three Arizona Companies Selected to Present at 2017 Rocky Mountain Life Science Investor and Partnering Conference

Avery Therapeutics, bioSyntagma, and Smart Brain Aging  will present at the October conference to feature 32 companies representing the future of healthcare from four states.

 

2017 Rocky Mountain Life Science Investor and Partnering Conference Announces Presenting Companies

October conference to feature 32 companies representing the future of healthcare from four states

DENVER–(BUSINESS WIRE)–Colorado BioScience Association (CBSA) today announced the full list of 32 companies selected to present at the 2017 Rocky Mountain Life Science Investor and Partnering Conference(RMLIPC). Representing the next wave of innovators in life science from Arizona, Colorado, New Mexico and Utah, the companies include emerging and established companies doing groundbreaking work in drug development, digital health, medical devices, therapies, and technologies.

The 5th Biennial Rocky Mountain Life Science Investor and Partnering Conference brings together leading investors, senior executives, and top life science innovators to cultivate partnerships in the dynamic Rocky Mountain region and discuss the future of healthcare. It allows investors to evaluate fresh opportunities and offers networking opportunities for attendees in a collaborative and informal setting.

The event, to be held in Vail, Colo. on October 2 and 3, attracts corporate leaders and investors to meet representatives from the 32 companies chosen by a selection committee made up of investors from the region.

April Giles, President & CEO of CBSA, says:

“The Rocky Mountain region attracts inventive companies working to transform human health. In the last five years, the states represented at The Rocky Mountain Life Science Investor and Partnering Conference attracted $1.9 Billion in bioscience investments. The participating companies represent the future of healthcare.”

Selected from more than 70 companies, the 32 presenting companies are:

ARIZONA

           
             

Scottsdale

         

Tucson

bioSyntagma, LLC

         

Avery Therapeutics

SMART Brain Aging

           
             

COLORADO

           
             

Aurora

         

Centennial

ClearSight

         

DZee Solutions

Galaxy Ophthalmics, LLC

           

HepQuant

         

Denver

Ocugen, Inc.

         

cliexa

Verkko Biomedical, LLC

         

ClinOne, Inc.

           

RxRevu

             

Boulder

           

Accera

         

Fort Collins

Brickell Biotech, Inc.

         

KromaTid

MBio Diagnostics, Inc.

         

VetDC, Inc.

miRagen

           

Neuraptive Therapeutics

         

Louisville

Precision Profile, Inc.

         

Eximis Surgical LLC

Prima-Temp

           

Sinopsys Surgical

         

Westminster

SomaLogic

         

ARCA Biopharma

SuviCa

           
             

Broomfield

         

Wheat Ridge

IM Therapeutics

         

Ablacon

             

NEW MEXICO

           
             

Albuquerque

         

Santa Fe

AAVP Biosystems, Inc.

         

AVISA

Agilvax

           
             

UTAH

           
             

Salt Lake City

           

ProLung

           
             

The 2017 Rocky Mountain Life Science Investor & Partnering Conference, led by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah, will kick off with a cocktail networking reception at Vail’s Hotel Talisa on October 2. The all-day conference begins on the morning of Tuesday, October 3.

Connect with CBSA: Twitter @COBioscience, Facebook and LinkedIn

Event hashtag: #RockyMtnBioInvest

About the Colorado BioScience Association

Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.

Posted in AZBio News.